PembroPrep: Accelerating efficiency and minimizing patient chair time
Journal of Oncology Pharmacy Practice · 16.11.2026
DOI: 10.1177/10781552261507673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Oncology Pharmacy Practice, online erschienen am 16.11.2026. Verfasst von Sarah Ritter und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH, USA. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Introduction
Prolonged infusion chair time negatively affects patient experience and limits operational capacity in outpatient oncology infusion settings. Advanced preparation and batching strategies reduce delays; however, the benefit of decentralized medication access has not been characterized. This study evaluated the impact of an anticipatory preparation strategy, scheduled batch preparation of pembrolizumab based on anticipated patient census data, with and without ADC point-of-care dispensing.
Methods
This single center, retrospective, pre-post study evaluated adult patients receiving pembrolizumab 200 mg monotherapy across three phases of operational changes: just-in-time compounding, after implementation of anticipatory preparation, and after anticipatory preparation plus ADC stocking in the infusion suite. The primary outcome was mean change in time from patient rooming to checkout. A secondary outcome was mean change in time from final product verification to medication administration. Outcomes were summarized using descriptive statistics and compared using one-way analysis of variance with Tukey's honestly significant difference tests.
Results
A total of 397 infusion encounters were analyzed. Mean rooming to checkout time decreased from 145.3 min at baseline to 140.4 min with anticipatory preparation and to 115.6 min following ADC stocking ( P = 0.0002). Mean dispense-to-administration time decreased from 19.5 min at baseline to 17.6 min with anticipatory preparation and to 6.7 min after ADC implementation (P < 0.001).
Conclusions
Anticipatory preparation of pembrolizumab was associated with modest reductions in medication administration time, while the addition of ADC stocking resulted in increased reduction of chair time. This approach may provide a scalable framework for improving operational efficiency in outpatient oncology infusion centers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, University Hospitals Cleveland Medical Center, 11100 Euclid Ave, Cleveland, OH, USA.
ORCID-Profile: Sarah Ritter, Jessie Rupp, Patricia Roberts
Zitieren
APA
Ritter, S., Rupp, J., Bogdanovich, L., & Roberts, P. (2026). PembroPrep: Accelerating efficiency and minimizing patient chair time. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552261507673
Vancouver
Ritter S, Rupp J, Bogdanovich L, Roberts P. PembroPrep: Accelerating efficiency and minimizing patient chair time. Journal of Oncology Pharmacy Practice. 2026. doi:10.1177/10781552261507673
BibTeX
@article{Ritter2026,
author = {Ritter, Sarah and Rupp, Jessie and Bogdanovich, Luke and Roberts, Patricia},
title = {PembroPrep: Accelerating efficiency and minimizing patient chair time},
journal = {Journal of Oncology Pharmacy Practice},
year = {2026},
doi = {10.1177/10781552261507673}
}
EUVIMED